C 27 H 20 FeN 2 O 2 S, monoclinic, P2
Source of material
All reagents and solvents werep urchased fromc ommercial sourcesa nd used as received. The title compound is obtained from aseriesofreactions involving the chemical synthesis of 2-naphthyl-1-ferrocenylsulfonyl-benzoimidazole from 2-naphthylbenzimidazole andferrocenyl sulfonyl chloride. Asolution of 2-naphthylbenzimidazole (1.01g ,5 .5 mmol) in acetonitrile (20 mL) was added to amixture of ferrocenylsulfonyl chloride (1.43 g, 5.0m mol) and anhydrous sodium carbonate (0.53 g, 5.0m mol) with constantly stirring [1, 2 ] . Them ixture was heated to reflux temperatures for 24 h [3] . The acetonitrile was evaporated under vacuum to leave abrown solid. The crude product was purified by columnchromatography (SiO 2 ,ethyl acetate: petroleume ther v/v =3 :7) to give the title compound (2.02 g, 82.1% yield) as adark red crystals, mp:520-522K.
Discussion
Benzimidazoles and their derivatives have been associated with various biological activities. Compounds containing benzimidazole moiety have shown good bactericidal, fungicidal and antimalarial activities [4] . The asymmetric unit of title compound contains one 2-naphthyl-1-ferrocenylsulfonyl-1H- 
